Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl Peptidase 4”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00683735
What this trial is testing

Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis

Who this might be right for
Diabetes
Michael A. Nauck 20
Large-scale testing (Phase 3)Study completedNCT01922817
What this trial is testing

DPP4inhibitors in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHypoglycaemia
University of Dundee 28
Post-approval studies (Phase 4)Study completedNCT02639637
What this trial is testing

Effect of DPP4 Inhibition on Vasoconstriction

Who this might be right for
Type 2 Diabetes Mellitus
Vanderbilt University 18
Large-scale testing (Phase 3)Study completedNCT03351478
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 770
Large-scale testing (Phase 3)Study completedNCT01798238
What this trial is testing

Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Handok Inc. 142
Testing effectiveness (Phase 2)UnknownNCT00824980
What this trial is testing

Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis

Who this might be right for
Psoriasis
Immune Technologies & Medicine GmbH 24
Testing effectiveness (Phase 2)Ended earlyNCT00370942
What this trial is testing

GW823093C For The Treatment Of Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 159
Early research (Phase 1)Study completedNCT05266404
What this trial is testing

Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components

Who this might be right for
Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
AstraZeneca 46
Not applicableStudy completedNCT03046576
What this trial is testing

Prognostic Value of Plasma DPP4 Activity in ST-elevation Myocardial Infarction Patients

Who this might be right for
Coronary AngiographyDipeptidyl Peptidase 4
Chinese PLA General Hospital 625
Not applicableStudy completedNCT01272583
What this trial is testing

Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery

Who this might be right for
Type 1 DiabetesHypoglycemia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 16
Post-approval studies (Phase 4)Study completedNCT02406443
What this trial is testing

The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion

Who this might be right for
Type 2 Diabetes
University Health Network, Toronto 36
Not applicableStudy completedNCT01465126
What this trial is testing

Enalapril in Collagen Type 4 Nephropathy

Who this might be right for
Collagen Type-4 Nephropathies
University of Sao Paulo 19
Large-scale testing (Phase 3)Study completedNCT01805830
What this trial is testing

Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy

Who this might be right for
Type 2 Diabetes
Handok Inc. 189
Not applicableStudy completedNCT00881543
What this trial is testing

"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

Who this might be right for
Diabetes Type 2
University of Sao Paulo General Hospital 45
Not applicableStudy completedNCT03081676
What this trial is testing

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea

Who this might be right for
Maturity-Onset Diabetes of the Young, Type 3
University Hospital, Gentofte, Copenhagen 20
Not applicableUnknownNCT03636763
What this trial is testing

Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?

Who this might be right for
Bullous Pemphigoid
Assistance Publique Hopitaux De Marseille 183
Testing effectiveness (Phase 2)Study completedNCT01452113
What this trial is testing

Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy

Who this might be right for
Diabetes Mellitus
University Hospital, Toulouse 21
Large-scale testing (Phase 3)Study completedNCT02104804
What this trial is testing

Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 953
Testing effectiveness (Phase 2)UnknownNCT00836940
What this trial is testing

A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Glenmark Pharmaceuticals Europe Ltd. (R&D) 480
Post-approval studies (Phase 4)Study completedNCT02192853
What this trial is testing

Correlation Between Plasma- and Endothelial DPP-4 Activity

Who this might be right for
Type 2 Diabetes Mellitus
University Hospital, Gentofte, Copenhagen 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation